Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,397.50
-2.50 (-0.05%)
At close: Aug 21, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 645.65 billion as of August 21, 2026. Its market cap has increased by 0.13% in one year.
Market Cap
645.65B
Enterprise Value
630.80B
Revenue
150.81B
Ranking
n/a
PE Ratio
29.93
Stock Price
5,397.50
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 645.65B, an increase of 290.82%. That is a compound annual growth rate of 13.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 645.65B | -1.93% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.86T |
| Lupin | 1.00T |
| Dr. Reddy's Laboratories | 978.76B |
| Abbott India | 557.70B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |